Close
Ben Lopman

Professor

Education

Affiliations

Projects

Papers

Baker JM, Tate JE, Leon J, Haber MJ, Pitzer VE, Lopman BA. (2020). Post-vaccination serum anti-rotavirus immunoglobulin A as a correlate of protection against rotavirus gastroenteritis across settings. The Journal of infectious diseases

Ai CE, Steele M, Lopman B. (2020). Disease burden and seasonal impact of improving rotavirus vaccine coverage in the United States: A modeling study. PloS one, 15(2)

Arrouzet CJ, Ellis K, Kambhampati A, Chen Y, Steele M, Lopman B. (2020). Population-level human secretor status is associated with genogroup 2 type 4 norovirus predominance. The Journal of infectious diseases

Olson DR, Lopman BA, Konty KJ, Mathes RW, Papadouka V, Ternier A, Zucker JR, Simonsen L, Grenfell BT, Pitzer VE. (2020). Surveillance data confirm multiyear predictions of rotavirus dynamics in New York City. Science advances, 6(9)

Baker JM, Dahl RM, Cubilo J, Parashar UD, Lopman BA. (2019). Effects of the rotavirus vaccine program across age groups in the United States: analysis of national claims data, 2001-2016. BMC infectious diseases, 19(1)

Zelner J, Adams C, Havumaki J, Lopman B. (2019). Understanding the importance of contact heterogeneity and variable infectiousness in the dynamics of a large Norovirus outbreak. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Lopman B, Hall A. (2019). Incomplete use of global data for aetiological attribution of diarrhoeal disease in the Global Burden of Disease study. The Lancet. Infectious diseases, 19(2)

Lewnard JA, Lopman BA, Parashar UD, Bennett A, Bar-Zeev N, Cunliffe NA, Samuel P, Guerrero ML, Ruiz-Palacios G, Kang G, Pitzer VE. (2019). Heterogeneous susceptibility to rotavirus infection and gastroenteritis in two birth cohort studies: Parameter estimation and epidemiological implications. PLoS computational biology, 15(7)

Baker JM, Tate JE, Steiner CA, Haber MJ, Parashar UD, Lopman BA. (2019). Longer-term Direct and Indirect Effects of Infant Rotavirus Vaccination Across All Ages in the United States in 2000-2013: Analysis of a Large Hospital Discharge Data Set. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 68(6)

Lopman B, Dahl R, Shah M, Parashar UD. (2018). Timing of Birth as an Emergent Risk Factor for Rotavirus Hospitalization and Vaccine Performance in the Postvaccination Era in the United States. American journal of epidemiology, 187(8)

Lopman BA, Pitzer VE. (2018). Waxing Understanding of Waning Immunity. The Journal of infectious diseases, 217(6)

Osuka H, Hall AJ, Wikswo ME, Baker JM, Lopman BA. (2018). Temporal Relationship Between Healthcare-Associated and Nonhealthcare-Associated Norovirus Outbreaks and Google Trends Data in the United States. Infection control and hospital epidemiology, 39(3)

O'Ryan M, Lopman BA. (2017). Parenteral protein-based rotavirus vaccine. The Lancet. Infectious diseases, 17(8)

Romero C, Tinoco YO, Loli S, Razuri H, Soto G, Silva M, Galvan P, Kambhampati A, Parashar UD, Kasper MR, Bausch DG, Simons MP, Lopman B. (2017). Incidence of norovirus-associated diarrhea and vomiting disease among children and adults in a community cohort in the Peruvian Amazon Basin. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 65(5)

Gheorghita S, Birca L, Donos A, Wasley A, Birca I, Cojocaru R, Melnick A, Ciobanu S, Mosina L, Cortese MM, Parashar UD, Lopman B. (2016). Impact of Rotavirus Vaccine Introduction and Vaccine Effectiveness in the Republic of Moldova. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, (62 Suppl 2)

Armah G, Pringle K, Enweronu-Laryea CC, Ansong D, Mwenda JM, Diamenu SK, Narh C, Lartey B, Binka F, Grytdal S, Patel M, Parashar U, Lopman B. (2016). Impact and Effectiveness of Monovalent Rotavirus Vaccine Against Severe Rotavirus Diarrhea in Ghana. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, (62 Suppl 2)

Head MG, Lopman BA. (2016). Norovirus in 2016-Emesis Aplenty but Clear Signs of Progress. The Journal of infectious diseases, (213 Suppl 1)

Lopman BA, Steele D, Kirkwood CD, Parashar UD. (2016). The Vast and Varied Global Burden of Norovirus: Prospects for Prevention and Control. PLoS medicine, 13(4)

Kambhampati A, Payne DC, Costantini V, Lopman BA. (2016). Host Genetic Susceptibility to Enteric Viruses: A Systematic Review and Metaanalysis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 62(1)

Grytdal SP, Rimland D, Shirley SH, Rodriguez-Barradas MC, Goetz MB, Brown ST, Lucero-Obusan C, Holodniy M, Graber C, Parashar U, Vinjé J, Lopman B. (2015). Incidence of Medically-Attended Norovirus-Associated Acute Gastroenteritis in Four Veteran's Affairs Medical Center Populations in the United States, 2011-2012. PLoS One, 10(5)

Gastañaduy PA, Vicuña Y, Salazar F, Broncano N, Gregoricus N, Vinjé J, Chico M, Parashar UD, Cooper PJ, Lopman B. (2015). Transmission of Norovirus Within Households in Quininde, Ecuador. The Pediatric infectious disease journal, 34(9)

Bellan SE, Pulliam JR, Pearson CA, Champredon D, Fox SJ, Skrip L, Galvani AP, Gambhir M, Lopman BA, Porco TC, Meyers LA, Dushoff J. (2015). Statistical power and validity of Ebola vaccine trials in Sierra Leone: a simulation study of trial design and analysis. The Lancet. Infectious diseases, 15(6)

Shioda K, Kambhampati A, Hall AJ, Lopman BA. (2015). Global age distribution of pediatric norovirus cases. Vaccine, 33(33)

Lopman BA, Trivedi T, Vicuña Y, Costantini V, Collins N, Gregoricus N, Parashar U, Sandoval C, Broncano N, Vaca M, Chico ME, Vinjé J, Cooper PJ. (2015). Norovirus Infection and Disease in an Ecuadorian Birth Cohort: Association of Certain Norovirus Genotypes With Host FUT2 Secretor Status. The Journal of infectious diseases, 211(11)

Barclay L, Park GW, Vega E, Hall A, Parashar U, Vinjé J, Lopman B. (2014). Infection control for norovirus. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 20(8)

Payne DC, Parashar UD, Lopman BA. (2015). Developments in understanding acquired immunity and innate susceptibility to norovirus and rotavirus gastroenteritis in children. Current opinion in pediatrics, 27(1)

Iturriza-Gómara M, Lopman B. (2014). Norovirus in healthcare settings. Current opinion in infectious diseases, 27(5)

Premkumar PS, Parashar UD, Gastanaduy PA, McCracken JP, de Oliveira LH, Payne DC, Patel MM, Tate JE, Lopman BA. (2015). Reduced rotavirus vaccine effectiveness among children born during the rotavirus season: a pooled analysis of 5 case-control studies from the Americas. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 60(7)

Ahmed SM, Hall AJ, Robinson AE, Verhoef L, Premkumar P, Parashar UD, Koopmans M, Lopman BA. (2014). Global prevalence of norovirus in cases of gastroenteritis: a systematic review and meta-analysis. The Lancet. Infectious diseases, 14(8)

Gastañaduy PA, Curns AT, Parashar UD, Lopman BA. (2013). Gastroenteritis hospitalizations in older children and adults in the United States before and after implementation of infant rotavirus vaccination. JAMA, 310(8)

Zelner JL, Lopman BA, Hall AJ, Ballesteros S, Grenfell BT. (2013). Linking time-varying symptomatology and intensity of infectiousness to patterns of norovirus transmission. PloS one, 8(7)

Rha B, Burrer S, Park S, Trivedi T, Parashar UD, Lopman BA. (2013). Emergency department visit data for rapid detection and monitoring of norovirus activity, United States. Emerging infectious diseases, 19(8)

Simmons K, Gambhir M, Leon J, Lopman B. (2013). Duration of immunity to norovirus gastroenteritis. Emerging infectious diseases, 19(8)

Gastañaduy PA, Hall AJ, Curns AT, Parashar UD, Lopman BA. (2013). Burden of norovirus gastroenteritis in the ambulatory setting--United States, 2001-2009. The Journal of infectious diseases, 207(7)

Lopman B, Vicuña Y, Salazar F, Broncano N, Esona MD, Sandoval C, Gregoricus N, Bowen MD, Payne D, Vaca M, Chico M, Parashar U, Cooper PJ. (2013). Household transmission of rotavirus in a community with rotavirus vaccination in Quininde, Ecuador. PLoS One, 8(7)

Lopman B, Simmons K, Gambhir M, Vinjé J, Parashar U. (2014). Epidemiologic implications of asymptomatic reinfection: a mathematical modeling study of norovirus. American journal of epidemiology, 179(4)

Lopman B, Kang G. (2014). In praise of birth cohorts: norovirus infection, disease, and immunity. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 58(4)

Trivedi TK, Desai R, Hall AJ, Patel M, Parashar UD, Lopman BA. (2013). Clinical characteristics of norovirus-associated deaths: a systematic literature review. American journal of infection control, 41(7)

Trivedi TK, DeSalvo T, Lee L, Palumbo A, Moll M, Curns A, Hall AJ, Patel M, Parashar UD, Lopman BA. (2012). Hospitalizations and mortality associated with norovirus outbreaks in nursing homes, 2009-2010. JAMA, 308(16)

Pitzer VE, Atkins KE, de Blasio BF, Van Effelterre T, Atchison CJ, Harris JP, Shim E, Galvani AP, Edmunds WJ, Viboud C, Patel MM, Grenfell BT, Parashar UD, Lopman BA. (2012). Direct and indirect effects of rotavirus vaccination: comparing predictions from transmission dynamic models. PLoS One, 7(8)

Hall AJ, Curns AT, McDonald LC, Parashar UD, Lopman BA. (2012). The roles of Clostridium difficile and norovirus among gastroenteritis-associated deaths in the United States, 1999-2007. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 55(2)

Desai R, Hembree CD, Handel A, Matthews JE, Dickey BW, McDonald S, Hall AJ, Parashar UD, Leon JS, Lopman B. (2012). Severe outcomes are associated with genogroup 2 genotype 4 norovirus outbreaks: a systematic literature review. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 55(2)

Lopman BA, Pitzer VE, Sarkar R, Gladstone B, Patel M, Glasser J, Gambhir M, Atchison C, Grenfell BT, Edmunds WJ, Kang G, Parashar UD. (2012). Understanding reduced rotavirus vaccine efficacy in low socio-economic settings. PloS one, 7(8)

Lopman BA, Payne DC, Tate JE, Patel MM, Cortese MM, Parashar UD. (2012). Post-licensure experience with rotavirus vaccination in high and middle income countries; 2006 to 2011. Current opinion in virology, 2(4)

Bartsch SM, Lopman BA, Hall AJ, Parashar UD, Lee BY. (2012). The potential economic value of a human norovirus vaccine for the United States. Vaccine, 30(49)

Lopman B, Gastañaduy P, Park GW, Hall AJ, Parashar UD, Vinjé J. (2012). Environmental transmission of norovirus gastroenteritis. Current opinion in virology, 2(1)

Lopman BA, Hall AJ, Curns AT, Parashar UD. (2011). Increasing rates of gastroenteritis hospital discharges in US adults and the contribution of norovirus, 1996-2007. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 52(4)

Pitzer VE, Viboud C, Lopman BA, Patel MM, Parashar UD, Grenfell BT. (2011). Influence of birth rates and transmission rates on the global seasonality of rotavirus incidence. Journal of the Royal Society, Interface, 8(64)

Pitzer VE, Patel MM, Lopman BA, Viboud C, Parashar UD, Grenfell BT. (2011). Modeling rotavirus strain dynamics in developed countries to understand the potential impact of vaccination on genotype distributions. Proceedings of the National Academy of Sciences of the United States of America, 108(48)

Lopman B. (2011). Air sickness: vomiting and environmental transmission of norovirus on aircraft. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 53(6)

Phillips G, Tam CC, Rodrigues LC, Lopman B. (2011). Risk factors for symptomatic and asymptomatic norovirus infection in the community. Epidemiology and infection, 139(11)

Lopman BA, Curns AT, Yen C, Parashar UD. (2011). Infant rotavirus vaccination may provide indirect protection to older children and adults in the United States. The Journal of infectious diseases, 204(7)

Patel MM, Tate J, Cortese M, Payne DC, Armstrong G, Parashar UD, Lopman B. (2010). The impact of indirect benefits of vaccination on postlicensure vaccine effectiveness estimates: A scenario analysis. Vaccine, 28(50)

Atchison C, Iturriza-Gomara M, Tam C, Lopman B. (2010). Spatiotemporal dynamics of rotavirus disease in Europe: can climate or demographic variability explain the patterns observed. The Pediatric infectious disease journal, 29(6)

Phillips G, Tam CC, Rodrigues LC, Lopman B. (2010). Prevalence and characteristics of asymptomatic norovirus infection in the community in England. Epidemiology and infection, 138(10)

Phillips G, Tam CC, Conti S, Rodrigues LC, Brown D, Iturriza-Gomara M, Gray J, Lopman B. (2010). Community incidence of norovirus-associated infectious intestinal disease in England: improved estimates using viral load for norovirus diagnosis. American journal of epidemiology, 171(9)

Lopman B, Armstrong B, Atchison C, Gray JJ. (2009). Host, weather and virological factors drive norovirus epidemiology: time-series analysis of laboratory surveillance data in England and Wales. PLoS One, 4(8)

Haustein T, Harris JP, Pebody R, Lopman BA. (2009). Hospital admissions due to norovirus in adult and elderly patients in England. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 49(12)

Lopman B, Nyamukapa C, Mushati P, Mupambireyi Z, Mason P, Garnett GP, Gregson S. (2008). HIV incidence in 3 years of follow-up of a Zimbabwe cohort--1998-2000 to 2001-03: contributions of proximate and underlying determinants to transmission. International journal of epidemiology, 37(1)

Lopman B, Gregson S. (2008). When did HIV incidence peak in Harare, Zimbabwe? Back-calculation from mortality statistics. PLoS One, 3(3)

Lopman B, Zambon M, Brown DW. (2008). The evolution of norovirus, the "gastric flu". PLoS medicine, 5(2)

Harris JP, Edmunds WJ, Pebody R, Brown DW, Lopman BA. (2008). Deaths from norovirus among the elderly, England and Wales. Emerging infectious diseases, 14(10)

Lopman B, Lewis J, Nyamukapa C, Mushati P, Chandiwana S, Gregson S. (2007). HIV incidence and poverty in Manicaland, Zimbabwe: is HIV becoming a disease of the poor?. AIDS (London, England), (21 Suppl 7)

Smith J, Mushati P, Kurwa F, Mason P, Gregson S, Lopman B. (2007). Changing patterns of adult mortality as the HIV epidemic matures in Manicaland, eastern Zimbabwe. AIDS (London, England), (21 Suppl 6)

Lopman BA, Gallimore C, Gray JJ, Vipond IB, Andrews N, Sarangi J, Reacher MH, Brown DW. (2006). Linking healthcare associated norovirus outbreaks: a molecular epidemiologic method for investigating transmission. BMC infectious diseases, (6)

Lopman BA, French KM, Baggaley R, Gregson S, Garnett GP. (2006). HIV-contaminated syringes are not evidence of transmission. AIDS (London, England), 20(14)

Lopman B. (2006). Noroviruses: simple detection for complex epidemiology. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 42(7)

Lopman BA, Barnabas RV, Boerma JT, Chawira G, Gaitskell K, Harrop T, Mason P, Donnelly CA, Garnett GP, Nyamukapa C, Gregson S. (2006). Creating and validating an algorithm to measure AIDS mortality in the adult population using verbal autopsy. PLoS medicine, 3(8)

Lopman BA, Barnabas R, Hallett TB, Nyamukapa C, Mundandi C, Mushati P, Garnett GP, Gregson S. (2006). Assessing adult mortality in HIV-1-afflicted Zimbabwe (1998 -2003). Bulletin of the World Health Organization, 84(3)

Lopman BA, Garnett GP, Mason PR, Gregson S. (2005). Individual level injection history: a lack of association with HIV incidence in rural Zimbabwe. PLoS medicine, 2(2)

Lopman B, Vennema H, Kohli E, Pothier P, Sanchez A, Negredo A, Buesa J, Schreier E, Reacher M, Brown D, Gray J, Iturriza M, Gallimore C, Bottiger B, Hedlund KO, Torvén M, von Bonsdorff CH, Maunula L, Poljsak-Prijatelj M, Zimsek J, Reuter G, Szücs G, Melegh B, Svennson L, van Duijnhoven Y, Koopmans M. (2004). Increase in viral gastroenteritis outbreaks in Europe and epidemic spread of new norovirus variant. Lancet, 363(9410)

Lopman BA. (2004). Emerging Themes in Epidemiology: Form and function. Emerging themes in epidemiology, 1(1)

Lopman BA, Reacher MH, Vipond IB, Hill D, Perry C, Halladay T, Brown DW, Edmunds WJ, Sarangi J. (2004). Epidemiology and cost of nosocomial gastroenteritis, Avon, England, 2002-2003. Emerging infectious diseases, 10(10)

Lopman BA, Reacher MH, Vipond IB, Sarangi J, Brown DW. (2004). Clinical manifestation of norovirus gastroenteritis in health care settings. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 39(3)

Lopman BA, Reacher M, Gallimore C, Adak GK, Gray JJ, Brown DW. (2003). A summertime peak of "winter vomiting disease": surveillance of noroviruses in England and Wales, 1995 to 2002. BMC Public Health, (3)

Lopman BA, Reacher MH, Van Duijnhoven Y, Hanon FX, Brown D, Koopmans M. (2003). Viral gastroenteritis outbreaks in Europe, 1995-2000. Emerging infectious diseases, 9(1)

Lopman BA, Adak GK, Reacher MH, Brown DW. (2003). Two epidemiologic patterns of norovirus outbreaks: surveillance in England and wales, 1992-2000. Emerging infectious diseases, 9(1)

Lopman BA, Tam CC. (2003). Epidemiologists: clinging to coat-tails or donning them?. International journal of epidemiology, 32(5)

Koopmans M, Vennema H, Heersma H, van Strien E, van Duynhoven Y, Brown D, Reacher M, Lopman B, . (2003). Early identification of common-source foodborne virus outbreaks in Europe. Emerging infectious diseases, 9(9)

Lopman B, van Duynhoven Y, Hanon FX, Reacher M, Koopmans M, Brown D, . (2002). Laboratory capability in Europe for foodborne viruses. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 7(4)